BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cabral WA, Tavarez UL, Beeram I, Yeritsyan D, Boku YD, Eckhaus MA, Nazarian A, Erdos MR, Collins FS. Genetic reduction of mTOR extends lifespan in a mouse model of Hutchinson-Gilford Progeria syndrome. Aging Cell 2021;20:e13457. [PMID: 34453483 DOI: 10.1111/acel.13457] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Trani JP, Chevalier R, Caron L, El Yazidi C, Broucqsault N, Toury L, Thomas M, Annab K, Binetruy B, De Sandre-giovannoli A, Levy N, Magdinier F, Robin JD. Mesenchymal stem cells derived from patients with premature aging syndromes display hallmarks of physiological aging. Life Sci Alliance 2022;5:e202201501. [DOI: 10.26508/lsa.202201501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Catarinella G, Nicoletti C, Bracaglia A, Procopio P, Salvatori I, Taggi M, Valle C, Ferri A, Canipari R, Puri PL, Latella L. SerpinE1 drives a cell-autonomous pathogenic signaling in Hutchinson-Gilford progeria syndrome. Cell Death Dis 2022;13:737. [PMID: 36028501 DOI: 10.1038/s41419-022-05168-y] [Reference Citation Analysis]
3 Mota-Martorell N, Jové M, Pamplona R. mTOR Complex 1 Content and Regulation Is Adapted to Animal Longevity. Int J Mol Sci 2022;23:8747. [PMID: 35955882 DOI: 10.3390/ijms23158747] [Reference Citation Analysis]
4 Jiang B, Wu X, Meng F, Si L, Cao S, Dong Y, Sun H, Lv M, Xu H, Bai N, Guo Q, Song X, Yu Y, Guo W, Yi F, Zhou T, Li X, Feng Y, Wang Z, Zhang D, Guan Y, Ma M, Liu J, Li X, Zhao W, Liu B, Finkel T, Cao L. Progerin modulates the IGF-1R/Akt signaling involved in aging. Sci Adv 2022;8:eabo0322. [DOI: 10.1126/sciadv.abo0322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mirisola MG, Longo VD. Yeast Chronological Lifespan: Longevity Regulatory Genes and Mechanisms. Cells 2022;11:1714. [PMID: 35626750 DOI: 10.3390/cells11101714] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
6 Benedicto I, Chen X, Bergo MO, Andrés V. Progeria: a perspective on potential drug targets and treatment strategies. Expert Opinion on Therapeutic Targets. [DOI: 10.1080/14728222.2022.2078699] [Reference Citation Analysis]
7 Mosevitsky MI. Progerin and Its Role in Accelerated and Natural Aging. Mol Biol 2022;56:125-46. [DOI: 10.1134/s0026893322020091] [Reference Citation Analysis]
8 Wang Y, Shilagardi K, Hsu T, Odinammadu KO, Maruyama T, Wu W, Lin CS, Damoci CB, Spear ED, Shin JY, Hsu W, Michaelis S, Worman HJ. Abolishing the prelamin A ZMPSTE24 cleavage site leads to progeroid phenotypes with near-normal longevity in mice. Proc Natl Acad Sci U S A 2022;119:e2118695119. [PMID: 35197292 DOI: 10.1073/pnas.2118695119] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Cabral WA, Tavarez UL, Beeram I, Yeritsyan D, Boku YD, Eckhaus MA, Nazarian A, Erdos MR, Collins FS. Genetic reduction of mTOR extends lifespan in a mouse model of Hutchinson-Gilford Progeria syndrome. Aging Cell 2021;20:e13457. [PMID: 34453483 DOI: 10.1111/acel.13457] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]